Czechia vs Japan: Previously treated cases tested for RR-/MDR-TB
Czechia
58.0%
in 2024
Japan
58.0%
in 2024
Czechia rank
140th
Japan rank
140th
Previously treated cases tested for RR-/MDR-TB over time
- Czechia
- Japan
How they compare
Czechia currently reports 58.0% against 58.0% in Japan, a difference of 0.0%.
The two have swapped places 5 times across 16 shared years of data; in 2007 it was Czechia ahead.
Czechia ranks 140th and Japan ranks 140th of 180 countries.
Czechia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Czechia | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 56.0% | 26.0% | 30.0% | Czechia |
| 2010s | 55.9% | 45.8% | 10.1% | Czechia |
| 2020s | 71.8% | 58.2% | 13.6% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Czechia or Japan?
- Czechia, at 58.0% against 58.0% in Japan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Czechia and Japan?
- 0.0%, with Czechia ahead.
- How many years of comparable data are there for Czechia and Japan?
- 16 years are reported by both, from 2007 to 2024.
- How do Czechia and Japan rank globally for previously treated cases tested for rr-/mdr-tb?
- Czechia ranks 140th and Japan ranks 140th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.